Physician profile
Nicholas E Engelbrecht
NPI 1891791844
$2,005.38
in general payments reported to CMS, 2019-2025
12 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $36.64 · 2021: $86.15 · 2022: $264 · 2023: $554 · 2024: $605 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,486.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $528.93 | 2019-2024 | Eylea Hd, Eylea |
| Genentech USA, INC. | $454.17 | 2019-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $241.40 | 2023-2025 | Izervay |
| Genentech, INC. | $141.15 | 2024 | Vabysmo |
| Biogen, INC. | $140.25 | 2022-2023 | |
| Ucb, INC. | $132.43 | 2022-2024 | Fintepla |
| Bausch & Lomb Americas INC. | $110.03 | 2022 | |
| Carl Zeiss Meditec, INC. | $104.43 | 2019-2020 | |
| Abbvie INC. | $72.32 | 2023-2024 | |
| Harrow Eye, LLC | $45.87 | 2024-2025 | Iheezo |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Allergan, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Engelbrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.